Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Ben Price acquired 5,000,000 shares of the firm’s stock in a transaction that occurred on Monday, March 31st. The shares were purchased at an average cost of A$0.01 ($0.01) per share, with a total value of A$60,000.00 ($35,928.14).
Percheron Therapeutics Price Performance
About Percheron Therapeutics
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Read More
- Five stocks we like better than Percheron Therapeutics
- How to Invest in the FAANG Stocks
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- What is the Nikkei 225 index?
- Disney 2025 Shareholders: Major Updates for Investors
- Dividend Capture Strategy: What You Need to Know
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
